2021
DOI: 10.2967/jnumed.121.263147
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Outcomes of Transarterial Radioembolization for Large Single Hepatocellular Carcinoma: A Comparison to Resection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 46 publications
0
7
0
Order By: Relevance
“…640 According to a retrospective cohort study of patients with a single HCC sized ≥5 cm at two Korean centers, 90 Y TARE showed similar OS and PFS compared to hepatic resection, with fewer side effects and superior safety. 641 Therefore, 90 Y TARE, like TACE, can minimize liver damage and maximize the therapeutic efficacy when the procedure is selectively performed through the tumor-feeding artery. Further studies are needed to select appropriate patients and to compare 90 Y TARE with other treatments.…”
Section: Tare Using 90 Y Microspheresmentioning
confidence: 99%
“…640 According to a retrospective cohort study of patients with a single HCC sized ≥5 cm at two Korean centers, 90 Y TARE showed similar OS and PFS compared to hepatic resection, with fewer side effects and superior safety. 641 Therefore, 90 Y TARE, like TACE, can minimize liver damage and maximize the therapeutic efficacy when the procedure is selectively performed through the tumor-feeding artery. Further studies are needed to select appropriate patients and to compare 90 Y TARE with other treatments.…”
Section: Tare Using 90 Y Microspheresmentioning
confidence: 99%
“…In a Korean single-center study of 90 Y TARE with over 150 Gy delivered to ≥ 5 cm HCC, the complete remission rate was 80% [ 640 ]. According to a retrospective cohort study of patients with a single HCC sized ≥ 5 cm at two Korean centers, 90 Y TARE showed similar OS and PFS compared to hepatic resection, with fewer side effects and superior safety [ 641 ]. Therefore, 90 Y TARE, like TACE, can minimize liver damage and maximize the therapeutic efficacy when the procedure is selectively performed through the tumor-feeding artery.…”
Section: Tace and Radioembolizationmentioning
confidence: 99%
“… 7 The larger the tumor, the greater the possibility of vascular invasion and the worse the histological differentiation. 8 Even after radical resection, the 5-year disease-free survival rate is still low. 9 Therefore, this study retrospectively analyzed the clinicopathological and prognostic data of patients with SLHCC who underwent radical surgical resection.…”
Section: Introductionmentioning
confidence: 99%